OBJECTIVES: Beta blocking agents are drugs of first choice in the treatment of hypertension. The aim of this study was to analyze the consumption of beta blocking agents in Serbia in the period from 2007 to 2011 year. METHODS: The data about the use of drugs were taken from the Agency for Drugs and Medical Devices of the Serbia. RESULTS: During the observed period in Serbia the consumption of selective beta blocking agents were dominant. The most frequently used drug from this group was metoprolol . During this five years the consumption of metoprolol is in steadily decreased. In 2007. it was 37.73 DDD/1000 inh/day, at the end of 2011. year the consumption was  22.13 DDD/1000 inh/day. On the second place in drug consumption in the same group of drugs was atenolol. Atenolol also recorded a decline in consumption. On the third place in drug consumption was bisoprolol. At the beginning of 2007. consumption of this drug was very small, gradually grew and reached its maximum in 2011. From the unselective beta blocking agents the most frequently used was propranolol and his consumption in the observed years was constant. CONCLUSIONS: In Serbia, in the observed period the consumption of beta blocking agents been mostly constant. From all drugs in C07 group the most frequently used group of drugs was C07AB. This research was supported by Provincial Secretariat for Science and Technological Development, Autonomous Province of Vojvodina project No 114-451-2458/2011 and by Ministry of Science, Republic of Serbia, project no 41012.